These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 12089941)
1. [Researches on pharmacological properties of some new xanthine derivatives]. Dănilă G; Profire L; Costuleanu M Rev Med Chir Soc Med Nat Iasi; 2000; 104(4):131-6. PubMed ID: 12089941 [TBL] [Abstract][Full Text] [Related]
2. [Xanthine derivative compounds potential activity in inflammatory process]. Dănilă G; Profire L; Costuleanu M Rev Med Chir Soc Med Nat Iasi; 2002; 107(2):391-6. PubMed ID: 12638299 [TBL] [Abstract][Full Text] [Related]
3. [Researches on methyl-xanthine series.XI. Synthesis and physicochemical characterization of some 7-R-1,3-dimethyl-xanthine derivatives]. Dănilă G; Rusu G; Alexandrescu GI; Profire L Rev Med Chir Soc Med Nat Iasi; 2003; 107(2):439-43. PubMed ID: 14755957 [TBL] [Abstract][Full Text] [Related]
4. A new class of antibronchospastic agents: 7-(2,2-dimethyl)propyl substituted xanthines. Bonacchi G; Agostini O; Di Marco G; Borgianni M; Ballati L; Boni P; Castellucci A; Evangelista S; Toja E Farmaco; 1995 May; 50(5):333-9. PubMed ID: 7626168 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity. Duhault J; Boulanger M; Lonchampt M; Tisserand F; Holstorp S; Saint-Romas G; Pennel L; Regnier G Arzneimittelforschung; 1987 Dec; 37(12):1353-62. PubMed ID: 2835053 [TBL] [Abstract][Full Text] [Related]
6. [Study of the cardiovascular properties of some new methyl-xanthine derivatives]. Profire L; Dănilă G; Nechifor M Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):872-6. PubMed ID: 14756037 [TBL] [Abstract][Full Text] [Related]
7. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine. Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists. Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity. Staneva D; Chakurova L; Ivanova N; Spasov V; Raynova L; Bogoslovova T Acta Physiol Pharmacol Bulg; 1984; 10(4):44-52. PubMed ID: 6535369 [TBL] [Abstract][Full Text] [Related]
10. Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position. Miyamoto K; Yamamoto Y; Kurita M; Sakai R; Konno K; Sanae F; Ohshima T; Takagi K; Hasegawa T; Iwasaki N J Med Chem; 1993 May; 36(10):1380-6. PubMed ID: 8496906 [TBL] [Abstract][Full Text] [Related]
11. Differentiation between bronchodilation and universal adenosine antagonism among xanthine derivatives. Persson CG; Karlsson JA; Erjefält I Life Sci; 1982 Jun; 30(25):2181-9. PubMed ID: 6287142 [TBL] [Abstract][Full Text] [Related]
12. Studies on alkyl-xanthine derivatives. II. Pharmacokinetic and pharmacodynamic studies of a new bronchodilator, 1-methyl-3-propylxanthine (MPX). Ruttikorn A; Takagi K; Nadai M; Kuzuya T; Ogawa K; Miyamoto K; Hasegawa T Jpn J Pharmacol; 1988 Nov; 48(3):341-7. PubMed ID: 3221535 [TBL] [Abstract][Full Text] [Related]
13. [The pharmacology of 1-propyl-3-methyl-7-(5-hydroxyhexyl) xanthine (HWA 153), a new bronchodilatory xanthine derivative]. Anagnostopoulos C; Komarek J Arzneimittelforschung; 1979; 29(7):1013-24. PubMed ID: 582992 [No Abstract] [Full Text] [Related]
14. Bronchodilator activity of theophylline derivatives substituted at the 7-position. Corsano S; Scapicchi R; Strappaghetti G Arch Pharm (Weinheim); 1994 Oct; 327(10):631-5. PubMed ID: 7826198 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel. Chappe V; Mettey Y; Vierfond JM; Hanrahan JW; Gola M; Verrier B; Becq F Br J Pharmacol; 1998 Feb; 123(4):683-93. PubMed ID: 9517388 [TBL] [Abstract][Full Text] [Related]
16. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists. Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111 [TBL] [Abstract][Full Text] [Related]
17. Interaction of netilmicin and theophylline at the smooth muscles of the isolated rat trachea. Kouvelas D; Argyriou A; Papaioannidou P; Salpigides G; Papaioannou S; Pangalis A; Paradelis AG J Chemother; 1993 May; 5 Suppl 1():229-30. PubMed ID: 19663065 [No Abstract] [Full Text] [Related]
18. Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions. Manzini S; Meini S; Giachetti A; Beani L; Borea PA; Antonelli T; Ballati L; Bacciarelli C Arzneimittelforschung; 1990 Nov; 40(11):1205-13. PubMed ID: 1707621 [TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationship study of some 7-substituted theophyllines. Türker L; Akgün H; Balkan A Arzneimittelforschung; 1998 Jan; 48(1):39-42. PubMed ID: 9522029 [TBL] [Abstract][Full Text] [Related]
20. Theophylline and cAMP inhibit lysophosphatidic acid-induced hyperresponsiveness of bovine tracheal smooth muscle cells. Sakai J; Oike M; Hirakawa M; Ito Y J Physiol; 2003 May; 549(Pt 1):171-80. PubMed ID: 12679373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]